2016 takes nightmarish turn, mega deals morph into mega problems for Wall Street


The new U.S. rules do not directly affect most inversion deals, in which an American company buys a foreign counterpart. If 2015 was a dream year for Wall Street's top dealmakers, 2016 is starting to take a nightmarish turn.



from Biotech News